EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

NIR II‐Guided Photoactivatable Silencing Polyplex Boosts Cancer Immunotherapy

Yuquan Zhang, Jie Wang, Tian Zhang, Dongsheng Tang, Haiyin Yang, Shuai Guo, Yuchuan Fan, Caixia Sun, Haihua Xiao, Yuanyu Huang iD, Yuhua Weng

Exploration · 2025-10 · 5 (5)

DOI: 10.1002/exp.20240047 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration, online erschienen am 30.05.2025. Verfasst von Yuquan Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Science, School of Interdisciplinary Science, Aerospace Center Hospital, Key Laboratory of Molecular Medicine and Biotherapy, Key Labo…. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Key Research and Development Program of China, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Photodynamic therapy (PDT) triggers immunogenic cell death (ICD) within the tumor microenvironment, consequently enhancing tumor immunotherapy. However, the maximum absorption wavelengths of first and second‐generation PDT photosensitizers limit the penetration depth of therapeutics, resulting in insufficient anti‐tumor outcomes. This study reports a custom‐designed polymer, PTSQ, which exhibits significant absorption in the near‐infrared region (NIR) window and fluorescence emission spectra within the NIR II range, demonstrating excellent PDT efficiency. Additionally, PTSQ self‐assembles into nanomicelles, exhibiting outstanding siRNA delivery. To further enhance tumor immunotherapy, we introduce an immune checkpoint blockade strategy and prepared PTSQ/siPD‐L1 complexes. We present a novel approach to tumor treatment by combining NIR light‐activated PDT and ICD to enhance siPD‐L1 therapy. At the cellular level, PTSQ/siPD‐L1 complexes exhibit potent induction of ICD while concurrently suppressing PD‐L1 gene expression. In vivo, these complexes significantly impede the growth of CT26, 4T1, and patient‐derived xenograft (PDX) tumors. This effect is achieved by promoting in situ ICD, which reverses tumor environment and activates immune cells in tumors and spleens, including T cells, dendritic cells (DCs), and macrophages. Overall, this study offers insights for the development of NIR II‐guided cancer immunotherapy and underscores the efficacy of PDT in conjunction with checkpoint blockade for cancer treatment.

Schlagwörter

Stichwörter der Autor:innen

NIR II‐guided photodynamic therapyPD‐L1cancer immunotherapyimmunogenic cell deathsmall interference RNA

Autor:innen und Institutionen

  • School of Life Science, School of Interdisciplinary Science, Aerospace Center Hospital, Key Laboratory of Molecular Medicine and Biotherapy, Key Laboratory of Medical Molecule Science and Pharmaceutics Engineering Beiji…
  • Beijing National Laboratory for Molecular Sciences, Laboratory of Polymer Physics and Chemistry Institute of Chemistry Chinese Academy of Sciences Beijing China.
  • University of Chinese Academy of Sciences Beijing China.
  • School of Chemistry Chemical Engineering and Biotechnology Nanyang Technological University Singapore Singapore.
  • School of Medical Engineering, School of Interdisciplinary Science, Affiliated Zhuhai People's Hospital Beijing Institute of Technology (BIT) Zhuhai China.
  • Advanced Technology Research Institute Beijing Institute of Technology (BIT) Jinan China.

ORCID-Profile: Yuanyu Huang

Förderung

  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Fundamental Research Funds for the Central Universities
  • Natural Science Foundation of Beijing Municipality

Zitieren

APA

Zhang, Y., Wang, J., Zhang, T., Tang, D., Yang, H., Guo, S., Fan, Y., Sun, C., Xiao, H., Huang, Y., & Weng, Y. (2025). NIR II‐Guided Photoactivatable Silencing Polyplex Boosts Cancer Immunotherapy. Exploration, 5(5). https://doi.org/10.1002/exp.20240047

Vancouver

Zhang Y, Wang J, Zhang T, Tang D, Yang H, Guo S, et al. NIR II‐Guided Photoactivatable Silencing Polyplex Boosts Cancer Immunotherapy. Exploration. 2025;5(5). doi:10.1002/exp.20240047

BibTeX
@article{Zhang2025,
  author = {Zhang, Yuquan and Wang, Jie and Zhang, Tian and Tang, Dongsheng and Yang, Haiyin and Guo, Shuai and Fan, Yuchuan and Sun, Caixia and Xiao, Haihua and Huang, Yuanyu and Weng, Yuhua},
  title = {NIR II‐Guided Photoactivatable Silencing Polyplex Boosts Cancer Immunotherapy},
  journal = {Exploration},
  year = {2025},
  volume = {5},
  number = {5},
  doi = {10.1002/exp.20240047}
}
Kostenlos starten →